Argent Advisors, Inc. Gilead Sciences, Inc. Transaction History

Argent Advisors, Inc.

$323 Million
Q3 2025

A detailed history of Argent Advisors, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Argent Advisors, Inc. holds 11,622 shares of GILD stock, worth $1.45 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares

11,622

Previous 10,824 7.37%

Holding current value

$1.45 Million

Previous $1.2 Million 7.5%

% of portfolio

0.4%

Previous 0.39%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 03, 2025	BUY	$108.22 - $120.47 $86,359 - $96,135	798 Added 7.37%	11,622 $1.29 Million
Q2 2025 Aug 07, 2025	BUY	$96.91 - $113.0 $38,667 - $45,087	399 Added 3.83%	10,824 $1.2 Million
Q1 2025 Apr 25, 2025	SELL	$89.14 - $117.41 $82,008 - $108,017	-920 Reduced 8.11%	10,425 $1.17 Million
Q4 2024 Feb 10, 2025	BUY	$83.95 - $97.9 $11,920 - $13,901	142 Added 1.27%	11,345 $1.05 Million
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $5,526 - $6,971	-83 Reduced 0.74%	11,203 $939,000
Q2 2024 Jul 29, 2024	BUY	$63.15 - $72.88 $33,658 - $38,845	533 Added 4.96%	11,286 $774,000
Q1 2024 May 01, 2024	SELL	$71.58 - $87.29 $21,545 - $26,274	-301 Reduced 2.72%	10,753 $787,000
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $12,382 - $14,042	-169 Reduced 1.51%	11,054 $895,000
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $2,144 - $2,339	29 Added 0.26%	11,223 $841,000
Q2 2023 Aug 04, 2023	BUY	$76.01 - $86.7 $22,726 - $25,923	299 Added 2.74%	11,194 $862,000
Q1 2023 Apr 21, 2023	SELL	$77.31 - $88.08 $36,799 - $41,926	-476 Reduced 4.19%	10,895 $903,000
Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $3,302 - $4,741	-53 Reduced 0.46%	11,371 $976,000
Q3 2022 Nov 08, 2022	BUY	$59.54 - $68.01 $23,280 - $26,591	391 Added 3.54%	11,424 $705,000
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $67,994 - $76,581	1,178 Added 11.95%	11,033 $682,000
Q1 2022 Apr 26, 2022	BUY	$57.92 - $72.58 $570,801 - $715,275	9,855 New	9,855 $580,000
Q1 2020 Apr 23, 2020	SELL	$62.63 - $80.22 $86,429 - $110,703	-1,380 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $85,035 - $93,536	1,380 New	1,380 $88,000

Others Institutions Holding GILD

# of Institutions

2,378

Shares Held

1.01B

Call Options Held

10.4M

Put Options Held

8.12M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $157B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argent Advisors, Inc. with notifications on news.

Account

Argent Advisors, Inc. Gilead Sciences, Inc. Transaction History